Sohum Trivedi, MD
Neurology with Special Qualifications in Child Neurology · Marlboro, NJNPI 1932620291
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,654 and has fallen 57.1% since, to $710 in 2025.
Across 194 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$755
- Neurelis, Inc.$500
- Jazz Pharmaceuticals Inc.$366
- SK Life Science, Inc.$338
- AbbVie$332
- Greenwich Biosciences, Inc.$331
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,934100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 39 | $755 |
| Neurelis, Inc. | 29 | $500 |
| Jazz Pharmaceuticals Inc. | 9 | $366 |
| SK Life Science, Inc. | 12 | $338 |
| AbbVie | 21 | $332 |
| Greenwich Biosciences, Inc. | 12 | $331 |
| Aucta Pharmaceuticals, Inc. | 12 | $168 |
| Pfizer | 10 | $167 |
| Livanova USA, Inc. | 7 | $152 |
| Lundbeck LLC | 7 | $123 |
| Lilly USA, LLC | 7 | $115 |
| Neuropace, Inc. | 1 | $102 |
| Otter Pharmaceuticals, LLC | 5 | $90 |
| AstraZeneca(2 entities) | 4 | $78 |
| Acadia Pharmaceuticals Inc | 2 | $34 |
| Immedica Pharma US, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Nobelpharma America, LLC | 1 | $24 |
| Novartis | 1 | $21 |
| Akcea Therapeutics, Inc. | 1 | $20 |
| Zogenix Inc. | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Sanofi | 1 | $17 |
| Novocure Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Aquestive Therapeutics, Inc. | 1 | $15 |
| Biocodex, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$257
- XCOPRI$125
- VALTOCO$125
- Fintepla$124
- RNS Neurostimulator Kit$102
How this compares
$3,934 in reported general payments places this provider in the 85th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
See all neurology with special qualifications in child neurology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 18 | $730 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Marlboro
- Jacqueline RomeroMarlboro$4K
- Juliann PaolicchiHackensack$80K
- Trevor DesouzaMorristown$14K
- Rao PasupuletiHamilton$11K
- Aliza AlterLivingston$9K
- Sara RubensteinHackensack$7K
- Carlos LastraNew Brunswick$5K
- Romana KulikovaGarwood$4K
- Rajeshwari MahalinghamNew Brunswick$3K
- Vikram BhiseNew Brunswick$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.